Pre-Conference Cardiometabolic Tech Summit

11:00 - 11:10 am

Opening Remarks

Chair: Anne L. Peters, MD

11:10 - 11:30 am

An Introduction to Big Data and Its Role in Cardiometabolic Health

Eric D. Peterson, MD

11:30 - 11:50 am

When is Genetic Testing Useful in Cardiometabolic Medicine

Elizabeth M. McNally, MD, PhD

1:20 - 2:05 pm

Real-World Evidence in Cardiometabolic Health

Lawrence Blonde, MD

2:05 - 2:15 pm

Expert Panel Discussion and Q & A

Moderator: Anne L. Peters, MD

Panel: Eric D. Peterson, MD; Elizabeth M. McNally, MD, PhD; Lawrence Blonde, MD

2:25 - 2:40 pm

New Generation Engagement: The New Frontier

Patrick Wayte

2:40 - 3:10 pm

Moving Beyond A1C: Diabetes Devices and Their Clinical Use

Anne L. Peters, MD

3:10 - 3:40 pm

Wearables and Digital Health in Arrhythmia Management: Where Are We Headed?

Mintu Turakhia, MD

3:40 - 4:00 pm

Expert Panel Discussion and Q & A

Moderator: Anne L. Peters, MD

Panelists: Mintu Turakhia, MD; Patrick Wayte

4:05 - 5:20 pm

Multidisciplinary Case Consults in Diabetes Management

Chair: Jay S. Skyler, MD
Panelists: George L. Bakris, MD; Christie M. Ballantyne, MD; Robert H. Eckel, MD; Irl B. Hirsch, MD; Julio Rosenstock, MD; Virginia Valentine, APRN-CNS, BC-ADM, CDE, FAADE

9:00 - 10:00 am

Challenging Lipid Management Cases: Addressing the Gaps

Chair: Christie M. Ballantyne, MD
Panelists: Kim K. Birtcher, PharmD; Leslie Cho, MD; Robert H. Eckel, MD; Margo Minissian, PhD, ACNP

11:45 am - 12:45 pm

Multidisciplinary Case Consults in Obesity/Lifestyle

Chair: Robert H. Eckel, MD
Panelists: George L. Bakris, MD; Shannon Christen, RD, CDE; Holly R. Wyatt, MD

6:30 - 7:45 am

CME Breakfast Symposium A

Addressing the Unmet Need of Diabetic Kidney Disease Progression: Beyond SGLT-2 Inhibitors and GLP-1 Ras

Chair: George L. Bakris, MD

Faculty: Rajiv Agarwal, MD; Ileana L. Piña, MD, MPH

Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.

12:20 - 1:35 pm

CME Lunch Symposium A

Reducing Cardiovascular Risk: A Paradigm Shift in T2DM Management

Chair: Robert H. Eckel, MD

Faculty: Lawrence Blonde; Tracy Y. Wang, MD

Supported by an educational grant from Novo Nordisk.

12:20 - 1:35 pm

CME Lunch Symposium B

6:30 - 7:45 am

CME Breakfast Symposium A

The Potassium Dilemma in HF and CKD: Challenges and Advancements in the Management of Hyperkalemia

Chair: George L. Bakris, MD

Faculty: Peter A. McCullough, MD, MPH; Biff F. Palmer, MD; Matthew R. Weir, MD

Supported by an educational grant from AstraZeneca and Relypsa, Inc.

12:00 - 1:15 pm

CME Lunch Symposium A

Challenges and Advances in the Diagnosis and Management of Heart Failure with Preserved Ejection Fraction

Chair: Mariell Jessup, MD, FAHA

Faculty: Javed Butler, MD, MPH, MBA; Alanna A. Morris, MD; Ileana L. Piña, MD, MPH

Multi-supported by educational grants from Abbott and Novartis Pharmaceuticals Corporation.

12:00 - 1:15 pm

CME Lunch Symposium B

Advances in Iron Repletion Therapy: Addressing the Burden of Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Chair: Peter A. McCullough, MD, MPH

Faculty: Biykem Bozkurt, MD; Andy Y. Lee, MD; Gurushner Panjrath, MD

Supported by an educational grant from American Regent.

7:20 - 8:35 pm

CME Dinner Symposium

Managing LDL-C to Reduce ASCVD Risk: Recent Advancements and Strategies to Optimize Patient Outcomes

Chaired by: Christie M. Ballantyne, MD

Faculty: Leslie Cho, MD

Multi-supported by educational grants from Sanofi US and Regeneron Pharmaceuticals and Esperion.

10:15 - 11:15 am

Morning Break & Exhibits

2:25 - 3:25 pm

Afternoon Break & Exhibits

5:25 - 6:25 pm

Welcome Reception

10:00 - 11:00 am

Morning Break & Exhibits

2:15 - 3:15 pm

Afternoon Break & Exhibits

5:20 - 6:20 pm

Happy Hour

Session I - Diabetes Management

7:55 - 8:00 am

Opening Remarks

Christie M. Ballantyne, MD

11:15 am - 12:05 pm

Lifestyle Interventions for Prevention of Diabetes and the Metabolic Syndrome

Edward S. Horton, MD

1:45 - 2:25 pm

Navigating Insulin Management in Patients with T2DM

Irl B. Hirsch, MD

3:25 - 4:05 pm

What to Choose? Initial Combination Therapy versus Sequential Therapy

4:05 - 5:20 pm

Multidisciplinary Case Consults in Diabetes Management

Chair: Jay S. Skyler, MD
Panelists: George L. Bakris, MD; Christie M. Ballantyne, MD; Robert H. Eckel, MD; Irl B. Hirsch, MD; Julio Rosenstock, MD; Virginia Valentine, APRN-CNS, BC-ADM, CDE, FAADE

Session II - Lipid Management

7:55 - 8:00 am

Opening Remarks

Christie M. Ballantyne, MD

8:00 - 8:30 am

Guidelines and Gaps in Lipid Management

Roger S. Blumenthal, MD

8:30 - 9:00 am

Treatment of High-Risk Patients with CVD and Elevated TGs: REDUCE-IT and Beyond

Deepak L. Bhatt, MD, MPH

Supported by an educational grant from Amarin Pharma, Inc.

9:00 - 10:00 am

Challenging Lipid Management Cases: Addressing the Gaps

Chair: Christie M. Ballantyne, MD
Panelists: Kim K. Birtcher, PharmD; Leslie Cho, MD; Robert H. Eckel, MD; Margo Minissian, PhD, ACNP

11:00 - 11:20 am

Updates in Lp(a)

Patrick M. Moriarty, MD, FACC, FACP

11:20 - 11:40 am

Role of Genetic Risk Scores for the Prevention of Cardiometabolic Disease

Amit V. Khera, MD

11:40 - 11:45 am

Closing Remarks

Christie M. Ballantyne, MD

Session III - HTN/HF Management

1:25 - 1:30 pm

Opening Remarks

George L. Bakris, MD

1:30 - 2:15 pm

Hypertension: Integrating the Guidelines and Addressing the Gaps

Chair: George L. Bakris, MD
Panelists: Aldo Peixoto, MD; Raymond R. Townsend, MD; Michael A. Weber, MD

3:15 - 3:55 pm

SGLT2 Inhibitors and Renal Preservation

George L. Bakris, MD

3:55 - 4:25 pm

Role of Metabolic Syndrome in HFpEF

Mariell Jessup, MD, FAHA

4:25 - 5:05 pm

Updates in HF and T2DM

Javed Butler, MD, MPH, MBA

5:05 - 5:10 pm

Closing Remarks

Session IV - Obesity/Lifestyle Management

7:55 - 8:00 am

Opening Remarks

Robert H. Eckel, MD

8:00 - 8:45 am

Nutrition Beats Attrition: The Low Hanging Friut for Cardiometabolic Health

Stephen Devries, MD

8:45 - 9:15 am

Updates on Leptin and Obesity

Martin Myers, MD, PhD

9:15 - 9:45 am

Mechanism for Benefit of Metabolic Surgery

Lee M. Kaplan, MD, PhD

9:45 - 10:15 am

Lifestyle Approaches to Weight Reduction - Challenges Before Us

Holly R. Wyatt, MD

10:25 - 11:05 am

Mechanisms of Obesity and Hypertension

George L. Bakris, MD; John E. Hall, PhD

11:05 - 11:45 am

NASH in a Dash

Christos S. Mantzoros, MD, DSc

11:45 am - 12:45 pm

Multidisciplinary Case Consults in Obesity/Lifestyle

Chair: Robert H. Eckel, MD
Panelists: George L. Bakris, MD; Shannon Christen, RD, CDE; Holly R. Wyatt, MD

12:45 - 12:50 pm

Closing Remarks

Robert H. Eckel, MD

9:30 - 10:15 am

Keynote

GLP-1 agonists: investigating the pleiotropic effects for cardio renal protection;What are the potential mechanisms involved?

Daniel J. Drucker, MD

8:00 - 9:30 am

FDA Update and Late Breaking Trials

Chair: Christie M. Ballantyne, MD

Presenters: Deepak L. Bhatt, MD, MPH; Robert H. Eckel, MD; Keith C. Ferdinand, MD; Jay S. Skyler, MD

12:05 - 1:05 pm

PME Lunch Symposium

Reviewing A1C and Cardiovascular Safety Data in T2D Therapies

Joshua M. Stolker, MD

4:15 - 5:15 pm

PME Light Bites Symposium

Cardiovascular Patient Cases

Eliot A. Brinton, MD

Sponsored by Amgen, Inc.

5:20 - 6:20 pm

PME Light Bites Symposium (Non-CME)

Expert Insights: Managing Cardiovascular Risk Based on a Landmark CV Outcomes Study

George Grunberger, MD

Sponsored by Amarin Pharma Inc.

6:30 - 7:30 pm

PME Dinner Symposium (Non-CME)

Jardiance^® (empagliflozin) tablets: Data from the comprehensive clinical development program

James H. O’Keefe, MD

Sponsored by Boehringer-Ingelheim.

6:30 - 7:30 pm

PME Dinner Symposium

Understanding the Clinical Implications of Heart Failure and Renal Dysfunction in Your Patients With Type 2 Diabetes

Peter A. McCullough, MD, MPH

Sponsored by AstraZeneca

6:30 - 7:15 pm

PME Light Bites Symposium

Understanding CKD in T2D: The Risks, Recognition, and Clinical Management

Peter A. McCullough, MD, MPH; Luiza Caramori, MD

Sponsored by Bayer.

5:25 - 6:25 pm

Welcome Reception

5:20 - 6:20 pm

Happy Hour

10:20 - 11:10 am

Workshop 1
ACC and ADA Unified Approach to CV Risk Reduction

2:30 - 3:15 pm

Workshop 2
Navigating Insulin Access and Cost

Irl B. Hirsch, MD

3:25 - 4:05 pm

Workshop 3
Progresses and Challenges in Obesity Pharmacotherapy

W. Timothy Garvey, MD

4:10 - 5:00 pm

Workshop 4

Kim K. Birtcher, PharmD

9:10 - 9:50 am

Workshop 5
Biomarkers in CVD - Global CVD Risk Assessment

Amit V. Khera, MD

10:05 - 10:45 am

Workshop 6
Statin Intolerance: Incidence, Prevalence, and Treatment

Leslie Cho, MD

2:25 - 3:10 pm

Workshop 7
When Do You Use Ambulatory BP Monitoring?

Raymond R. Townsend, MD

4:30 - 5:10 pm

Workshop 8
The Role of Potassium-Binding Agents in Optimizing HF Guidelines

Ileana L. Piña, MD, MPH